Clinical Study on the Efficacy and Safety of Iparomlimab and Tuvonralimab Injection Combined With Nab-Paclitaxel in Neoadjuvant Therapy for Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
Clinical trial NCT07493993 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07493993
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-01
- Primary completion
- 2028-05-31
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.